Reciprocal relationships between insulin resistance and endothelial dysfunction: Insights from therapeutic interventions

Journal of Central South University (Medical Sciences)

Volumn 31, Issue 3, 2006, Pages 305-312

  Quon, Michael J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Diabetes; Endothelial dysfunction; Hypertension; Insulin resistance

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN RECEPTOR; INSULIN SENSITIZING AGENT; LOSARTAN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110; PROTEIN P85; PROTEIN SERINE KINASE; PROTEIN SH2; RAMIPRIL; RAS PROTEIN; SOS PROTEIN; TYROSINE;

CLINICAL TRIAL; DIET RESTRICTION; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; EXERCISE; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INSULIN BINDING; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; MEDITERRANEAN DIET; METABOLIC SYNDROME X; MUSCLE BLOOD FLOW; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; REVIEW; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NITRIC OXIDE;

EID: 33745912531     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Reaven GM. Role of insulin resistance in human disease (syndrome X): An expanded definition[J]. Annu Rev Med, 1993, 44:121-131. (Review)
2. McVeigh GE, Cohn JN. Endothelial dysfunction and the metabolic syndrome[J]. Curr Diab Rep, 2003, 3(1):87-92. (Review)
3. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence[J]. Diabetes Care, 2005, 28(7):1769-1778. (Review)
4. Sedaghat AR, Sherman A, Quon MJ. A mathematical model of metabolic insulin signaling pathways[J]. Am J Physiol Endocrinol Metab, 2002, 283(5):E1084-1101.
5. 2+ but requires phosphorylation by Akt at Ser(1179)[J]. J Biol Chem, 2001, 276(32): 30392-30398.
6. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial Cells[J]. J Clin Invest, 1996, 98(4):894-898.
7. Zeng G, Nystrom FH, Ravichandran LV, et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells [J]. Circulation, 2000, 101(13):1539-1545.
8. Montagnani M, Ravichandran LV, Chen H, et al. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells [J]. Mol Endocrinol, 2002, 16(8):1931-1942.
9. Potenza MA, Marasciulo FL, Chieppa DM, et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production[J]. Am J Physiol Heart Circ Physiol, 2005, 289(2): H813-822.
10. Vincent MA, Montagnani M, Quon MJ. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium[J]. Curr Diab Rep, 2003, 3(4):279-288. (Review)
11. Cardillo C, Nambi SS, Kilcoyne CM, et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm[J]. Circulation, 1999, 100(8):820-825.
12. Grubb B, Snarr JF. Effect of flow rate and glucose concentration on glucose uptake rate by the rat limb[J]. Proc Soc Exp Biol Med, 1977, 154(1):33-36.
13. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids[J]. Diabetologia, 2002, 45(5):623-634.
14. Potenza MA, Marasciulo FL, Tarquinio M, et al. Rosiglitazone improves hypertension in spontaneously hypertensive rats (SHR) by decreasing endothelial MAP kinase signaling and endothelin-1 (ET-1) secretion[J]. Diabetes, 2005, 54(suppl 1):A320.
15. Fujishima S, Ohya Y, Nakamura Y, et al. Troglitazone, an insulin sensitizer, increases forearm blood flow in humans[J]. Am J Hypertens, 1998, 11(9):1134-1137.
16. Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus[J]. J Am Coll Cardiol, 2001, 37(5):1344-1350.
17. Maeda N, Takahashi M, Funahashi T, et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein[J]. Diabetes, 2001, 50(9):2094-2099.
18. Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells[J]. J Biol Chem, 2003, 278(45):45021-45026.
19. Nolan JJ, Ludvik B, Beerdsen P, et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone[J]. N Engl J Med, 1994, 331(18):1188-1193.
20. Panunti B, Kunhiraman B, Fonseca V. The impact of antidiabetic therapies on cardiovascular disease[J]. Curr Atheroscler Rep, 2005, 7(1):50-57. (Review)
21. Koh KK, Quon MJ, Han SH, et al. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients[J]. Circulation, 2004, 110(24): 3687-3692.
22. Koh KK, Quon MJ, Han SH, et al. Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with Type 2 diabetes[J]. Hypertension, 2005, 45(6):1088-1093.
23. Yusuf S, Gerstein H, Hoogwerf B, et al. Ramipril and the development of diabetes[J]. JAMA, 2001, 286(15):1882-1885.
24. No authors listed. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart outcomes prevention evaluation study investigators[J]. Lancet, 2000, 355(9200): 253-259.
25. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in Type 2 diabetic patients[J]. Arterioscler Thromb Vasc Biol, 2000, 20(6):1595-1599.
26. Monzillo LU, Hamdy O, Horton ES, et al. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance[J]. Obes Res, 2003, 11(9):1048-1054.
27. Esposito K, Marfella R, Ciotola M, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial[J]. JAMA, 2004, 292(12):1440-1446.
28. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial[J]. JAMA, 2003, 289(4):1799-1804.